需要D1多巴胺受体的激活,以实现D2激动剂效应的突触后表达
Science (New York, N.Y.)
|May 8, 1987
概括
需要同时刺激D1和D2多巴胺受体,以获得多巴胺对基底腺神经元和行为的作用. 这一发现挑战了D2受体单独调解这些反应的观点.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 行为科学 行为科学
背景情况:
- 多巴胺受体,特别是D1和D2亚型,在调节基底功能和运动行为方面发挥着至关重要的作用.
- 以前的研究表明,D2多巴胺受体可能独立调解由多巴胺激动剂诱导的行为和神经生理变化.
研究的目的:
- 为了研究D1和D2多巴胺受体在基底腺神经元活动和运动行为中的协同作用.
- 为了确定D2受体介导的效应是否依赖于由内源性多巴胺同时刺激D1受体.
主要方法:
- 电生理学记录了大鼠的基底质神经元.
- 评估自发运动活动和刻板印象的行为.
- 使用D1和D2多巴胺受体激动剂和对抗剂的药理学操纵.
- 使用alpha-methyl-rho-tyrosine来消耗内源性多巴胺.
主要成果:
- D2选择性激动剂的神经生理学和行为效应在被耗尽内源性多巴胺的老鼠中显著减弱.
- 非选择性多巴胺激动剂或D1和D2激动剂的组合产生强大的效果,无论内源性多巴胺水平如何.
- 这些发现表明,D2受体激素的有效性取决于内源性多巴胺对D1受体的作用.
结论:
- 这些结果挑战了D2多巴胺受体单独调解多巴胺诱导的基底输出和行为变化的观念.
- 这些效应需要同时刺激D1和D2多巴胺受体.
- D1和D2多巴胺受体之间的协同相互作用对于调节基底腺功能和运动控制至关重要.
相关概念视频
01:29Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
01:03Dose-Response Relationship: Overview
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
01:25Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
01:29The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
01:27Adrenergic Neurons: Neurotransmission
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...